Plain-English translation of NCT05772923 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two treatment strategies for people with rectal cancer who have responded well to initial radiation therapy but still have a small amount of remaining tumor. The study tests whether contact x-ray brachytherapy (a focused radiation boost directly to the tumor site) or waiting longer with possible local removal of the remaining tissue can help patients avoid major bowel surgery while still controlling their cancer.
Standard treatment for rectal cancer often requires removing the entire rectum, which can significantly affect quality of life and bodily functions. This trial exists to find safer ways to treat rectal cancer that preserve the organ and allow patients to maintain normal bowel function when possible.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups. One group will receive contact x-ray brachytherapy—three focused radiation treatments given over several weeks. The other group will wait 6–8 more weeks for the cancer to continue shrinking, then be re-evaluated and possibly have a minor removal procedure. Both groups will have check-ups every 3 months to monitor your response, and if your cancer fully responds, you'll enter a close monitoring approach instead of having major surgery.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
Netherlands